B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function

B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function

BACKGROUND The effect of impaired kidney function on B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) is vague. This study was performed to examine the effect of kidney dysfunction on the afore-mentioned markers and determine appropriate cutoffs for systolic heart failure (SHF). METHODS In this cross sectional study adults with estimated glomerular filtration rate (eGFR) <60...

Author's response to reviews Title: B-Type Natriuretic Peptide versus Amino Terminal Pro-B Type Natriuretic Peptide: Selecting the optimal heart failure marker in patients with impaired kidney function. Authors:

Amino-terminal pro-C-type natriuretic peptide in heart failure.

The levels and pathophysiological role of amino terminal C-type natriuretic peptide in heart failure are unknown. The potential of plasma amino-terminal C-type natriuretic peptide (N-CNP) as a marker of cardiac function was investigated in symptomatic patients. In 305 patients with recent-onset dyspnea and/or peripheral edema, presenting to primary care, assay of plasma amino-terminal C-type na...

Plasma Amino-Terminal B-Type Natriuretic Peptide

Measured by Elecsys 2010 Assay in a Trial of Hormoneguided Treatment for Heart Failure, Richard W. Troughton, Christopher M. Frampton, Timothy G. Yandle, Eric A. Espiner, Gary Nicholls, and Mark Richards (Christchurch Cardioendocrine Research Group, Christchurch School of Medicine and Health Sciences, Christchurch, 8001 New Zealand; * address correspondence to this author at: Department of Medi...

Cocoa flavanols reduce N‐terminal pro‐B‐type natriuretic peptide in patients with chronic heart failure

AIMS Poor prognosis in chronic heart failure (HF) is linked to endothelial dysfunction for which there is no specific treatment currently available. Previous studies have shown reproducible improvements in endothelial function with cocoa flavanols, but the clinical benefit of this effect in chronic HF has yet to be determined. Therefore, the aim of this study was to assess the potential therape...